Glenmark Pharmaceuticals Inc., USA (Glenmark) announces the launch1 of Clindamycin Phosphate Foam, 1%. Glenmark's Clindamycin ...

Results: Glenmark Pharmaceuticals posted a net profit of ₹348 crore in Q3 FY25, reversing a ₹351 crore loss YoY. Revenue ...

Glenmark Pharmaceuticals reports strong revenue growth and expansion plans for dermatology and respiratory portfolios in ...

Glenmark Pharmaceuticals reported a consolidated profit after tax of Rs 348 crore in Q3 FY25, driven by strong regional ...

The company reported a loss of Rs 351 crore in the comparable quarter last year, hurt by sluggish sales in India and charges ...

India's Glenmark Pharmaceuticals reported third-quarter profit below estimates on Friday due to bleak U.S. demand for its long-term illness drugs.

Glenmark Pharmaceuticals reported a significant profit of Rs 348 crore for Q3 2024, rebounding from a Rs 351 crore loss in ...

Glenmark Pharmaceuticals on Friday said its consolidated profit after tax stood at Rs 348 crore for the third quarter ended ...

Aditya Birla Fashion & Retail and Dish TV will be among 696 firms to release their reports for the Oct-Dec 2024 quarter ...

Glenmark launches Latanoprost Ophthalmic Solution, targeting $113.5 million market, showcasing commitment to quality eye care ...

Key companies announcing their third quarter results include Samvardhana Motherson, RVNL, Glenmark, Swan Energy, and Zen Tech ...

Glenmark Pharmaceuticals launches a generic ophthalmic solution for glaucoma in the US market, adding to its growing ...